[Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

[1]  E. Stip,et al.  Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial , 2006, Current medical research and opinion.

[2]  R. Rosenheck,et al.  Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia. , 2006, The American journal on addictions.

[3]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[4]  P. Falkai,et al.  Schizophrenie und Sucht , 2005 .

[5]  Alan I Green,et al.  Improving the Care of Individuals with Schizophrenia and Substance Use Disorders: Consensus Recommendations , 2005, Journal of psychiatric practice.

[6]  A. Green,et al.  Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism? , 2005, Current psychiatry reports.

[7]  S. Sayers,et al.  Cocaine Abuse in Schizophrenic Patients Treated With Olanzapine Versus Haloperidol , 2005, The Journal of nervous and mental disease.

[8]  D. Tan,et al.  Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect? , 2005, Journal of psychopharmacology.

[9]  K. Carey.  Substance use reduction in the context of outpatient psychiatric treatment: A collaborative, motivational, harm reduction approach , 1996, Community Mental Health Journal.

[10]  N. Kathmann,et al.  Prevalence of alcohol and drug abuse in schizophrenic inpatients , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[11]  P. Falkai,et al.  [Acute treatment of schizophrenia]. , 2004, Fortschritte der Neurologie-Psychiatrie.

[12]  E. Gouzoulis-Mayfrank.  Doppeldiagnose Psychose und Sucht , 2004, Der Nervenarzt.

[13]  J. Lieberman,et al.  First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol , 2004, Schizophrenia Research.

[14]  F. Gawin.  Neuroleptic reduction of cocaine-induced paranoia but not euphoria? , 2004, Psychopharmacology.

[15]  A. Green,et al.  Pharmacotherapy for schizophrenia and co-occurring substance use disorders , 2003, Current psychiatry reports.

[16]  D. Perantie,et al.  Cocaine and Amphetamine Use in Patients With Psychiatric Illness: A Randomized Trial of Typical Antipsychotic Continuation or Discontinuation , 2003, Journal of clinical psychopharmacology.

[17]  K. Mueser,et al.  Disulfiram treatment for alcoholism in severe mental illness. , 2003, The American journal on addictions.

[18]  E. Stip,et al.  Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses , 2003, International clinical psychopharmacology.

[19]  M. Soyka,et al.  Flupenthixol in Relapse Prevention in Schizophrenics with Comorbid Alcoholism: Results from an Open Clinical Study , 2003, European Addiction Research.

[20]  R. Weisman.  Quetiapine in the Successful Treatment of Schizophrenia with Comorbid Alcohol and Drug Dependence: A Case Report , 2003, International journal of psychiatry in medicine.

[21]  A. Green,et al.  Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone , 2003, Schizophrenia Research.

[22]  Andrew H. Miller,et al.  Relationship of Clinical Symptoms and Substance Use in Schizophrenia Patients on Conventional Versus Atypical Antipsychotics , 2003, The American journal of drug and alcohol abuse.

[23]  R. Petty,et al.  Olanzapine treatment for patients with schizophrenia and substance abuse. , 2001, Journal of substance abuse treatment.

[24]  J. Krystal,et al.  A neurobiological basis for substance abuse comorbidity in schizophrenia , 2001, Biological Psychiatry.

[25]  K. Mueser,et al.  Six-month outcomes for patients who switched to olanzapine treatment. , 2001, Psychiatric services.

[26]  E. Cantor-Graae,et al.  Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden , 2001, Schizophrenia Research.

[27]  S. Maxwell,et al.  Use of Naltrexone in the Treatment of Alcohol Use Disorders in Patients with Concomitant Major Mental Illness , 2000, Journal of addictive diseases.

[28]  S. Woods,et al.  Significant interaction between clozapine and cocaine in cocaine addicts. , 2000, Drug and alcohol dependence.

[29]  M. Berk,et al.  Risperidone compared to haloperidol in cannabis-induced psychotic disorder: A double blind randomized controlled trial. , 2000 .

[30]  M. Berk,et al.  A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial. , 1999, International clinical psychopharmacology.

[31]  R. Conley,et al.  Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse , 1998, Schizophrenia Research.

[32]  S. Evans,et al.  Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. , 1998, The American journal of drug and alcohol abuse.

[33]  B. Dickey,et al.  Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. , 1996, American journal of public health.

[34]  M. Soyka.  Dual Diagnosis in Patients with Schizophrenia , 1996 .

[35]  Lawrence B. Inderbitzin,et al.  Substance use: a powerful predictor of relapse in schizophrenia , 1996, Schizophrenia Research.

[36]  R. Drake,et al.  A Scale for Assessing the Stage of Substance Abuse Treatment in Persons with Severe Mental Illness , 1995, The Journal of nervous and mental disease.

[37]  P. Sand,et al.  Successful Treatment with Flupenthixol Decanoate of a Patient with both Schizophrenia and Alcoholism , 1995, Pharmacopsychiatry.

[38]  S. Southwick,et al.  Effects of Cocaine on Hospital Course in Schizophrenia , 1993, The Journal of nervous and mental disease.

[39]  S. Soni,et al.  Alcohol abuse in chronic schizophrenics: implications for management in the community , 1991, Acta psychiatrica Scandinavica.

[40]  D S Rae,et al.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. , 1990, JAMA.

[41]  M. Kiefer,et al.  Tardive dyskinesia in psychiatric patients with substance use disorders. , 1990, The American journal of drug and alcohol abuse.

[42]  T. Kosten,et al.  Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome? , 1988, The American journal of drug and alcohol abuse.